Cerebrovascular reactivity to acetazolamide in (Senile) dementia of Alzheimer’s type: Relationship to disease severity

Dementia and Geriatric Cognitive Disorders

Volumn 6, Issue 2, 1995, Pages 73-82

  Stoppe, Gabriela ^a   Schütze, Rainer ^a   Kögler, Andreas ^a   Staedt, Jürgen ^a   Munz, Dieter L ^b   Emrich, Dieter ^a   Rüther, Eckart ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Acetazolamide; Alzheimer s disease; Cerebral blood flow; Single photon emission tomography

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENERVATION; DEPRESSION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; MALE; NEUROPATHOLOGY; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENILE DEMENTIA; VASCULAR AMYLOIDOSIS; WHITE MATTER;

ACETAZOLAMIDE; AGED; ALZHEIMER DISEASE; ANXIETY; CEREBROVASCULAR CIRCULATION; COGNITION; FEMALE; HUMAN; MALE; MIDDLE AGE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 0028933502     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106925     Document Type: Article

References (83)

1. Johnson KA, Holman BL, Muiler SP: Single photon emission compurcd tomography in Alzheimer’s disease. Arch Neurol 1988.45:392-396.
2. Perani D, Di Piero V, Vallar G, Cappa S, Mcs-sa C, Bollini G, Berli A, Passafiumc D, Scarla-io G, Gerundini P, Lenzi GL, Fazio F: Tcehne-tmm-99m HMPAOSPECT. Study of regional cerebral perfusion in early Alzheimer’s disease. JNtid Mod 1988;29:1507-1514.
3. Burns A, Philpot MP, Cosla DC, Ell PJ, Levy R: The investigation of Alzheimer’s disease with single photon emission tomography, J Neurol Ncurosurg Psychiatrv 1989;52;248-253.
4. A Pearlson GD, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, Noga T, Tunc Lli: Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer’s disease. Arch Gen Psychiatry 1992;49:402-408.
5. Duara R, Grady C, Hasby J, Sundaram M, Cutler NR, Hcston L, Moore A, Schlageter N, Larson S, Rapoport SL.. Posiiran emission lo-mographv in Alzheimer’s disease. Neurologv 1986:36:879-887.
6. Hasby JV, Grady CL, Duara R, Sehlageter N, Bcrg G, Rapoport SI; Ncurocortical metabolic abnormalities precede nonmcmory cognitive defects in early Alzhcimcr’s-type dementia. Arcli Neurol 1986:43:882-883.
7. Hciss WD, Kessler J, Szclies B, Grand M, Fink G, Hcrholz K: Positron emission tomography in the differential diagnosis of organic dementias. J Neural Transm 1991:33(suppl);13-19.
8. Rapoport SI: Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain MetabRev 1991;3:297-335.
9. Fraekowiak RSJ, Pozzilti C, Lcgg NJ, DuBou-lay GH, Marshal J, Lenzi GL, Jones T: Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygcn-15 and positron tomography. Brain 1981;104:753-778.
10. Meyer JS, Rogers RL, Moitel KF: Progressive cerebral ischemia antedates cerebrovascular symptoms by two years. Ann Neurol 1984:16: 314-320.
11. Rogers RL, Meyer JS, Mortd KF, Mahurin RK, Judd BW: Decreased cerebral blood flow precedes mulii-inlarcl-dementia, but follows senile dementia of Alzheimer type. Neurology 1986;36:1-6.
12. Englund E, Bnin A, Ailing C: While matter changes in dementia of Alzheimer’s type Biochemical and neuropathological correlates. Brain 1988;111:1425-1439.
13. lanota I, Mirscn TR, Hachinski VC, Lee DH, Merskey H; Neuropathology correlates of leu-ko-araiosis. Arch Neurol 1989:46:1124-1128.
14. Scheibel AB, Duong T, Tomiyasu U: Dencrva-lion microangiopathy in senile dementia. Alzheimer type. Alzheimer Dis Assoc Disord 1987:11:19-37.
15. Johnson KA, Davis KR, Buonanno FS, Brady TJ, Rosen TJ, Growdon JH: Comparison of magnetic reasonance and roentgen ray computed tomography in dementia. Arch Neurol 1987;44:1075-1080.
16. Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horowitz B: White matter hyperintensities in dementia of Alzheimer’s type and in healthy subjects without cerebrovascular risk factors, A magnetic resonance imaging study. Arch Neurol 1990:47: 1306-1310.
17. Schmidt R: Comparison of magnetic resonance imaging in Alzheimer’s disease, vascular dementia and normal aging. Eur Neurol 1992:32: 164-169.
18. Leys D, Soetart G, Petit H, Fauquette A, Pruvo JP, Stcinling MP: Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer’s disease and normal aging. Arch Neurol 1990:47: 524-527.
19. Rezck DL, Morris JC, Fulling K.H, Gado MH: Periventricular white matter luccncies in senile dementia of the Alzheimer type and normal aging. Neurology 1987;37:1365-1368.
20. Englund E, Brun A, Pcrsson B: Corrclalions between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987; 1:156-170.
21. Kirkpairick JB, Hayman LA; White matter lesions in MR imaging of clinically healthy brains or elderly subjects: Possible pathologic basis. Radiology 1987; 162:509-511.
22. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 1986;17:1084-1089.
23. Knop J, Thic A, Fuchs C, Sicpmann GZ.: Eumer H:9,mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease. Stroke 1992;33:1733-1742.
24. Sullivan HG, Kingsbury TB, Morgan ME, Jeff-coat RD, Allison JD, Goode JJ, McDonnell DE: The rCBF response to diamox in normal subjects and cerebrovascular disease patients, J Ncurosurg 1987;67:525-534.
25. Rogg J, Rustigliano M, Yonas H, Johnson DW, Pentheny S, Latehaw Re: The acetazolamide challenge: Imaging techniques designed to evaluate cerebral blood flow reserve. AJNR [989; 10:803-810.
26. Dahl A, Lindcgaard KF, Russell D, Nyberg-Hansen R, Rootwclt K, Sortebcrg W, Norncs H: A comparison of transcranial Dopplcr and cerebral blood flow studies to assess cerebral vasoreactivity. Stroke 1992:23:15-19.
27. Bonte FJ, Devous MD, Reisch JS; The effect of cerebral blood flow in normal human subjects as measured by single photon emission computed tomography. Invest Radiol 1988:23: 564-568.
28. McKhann G, Drachmann D, Folstein M, Katz-man R, Price D, Stadlan EM; Clinical diagnosis or Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the aus-piccsof Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984:34:939-944.
29. APA-American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3. Revised (DSM-II1-R). Washington. American Psychiatric Association. 1987.
30. Hachinski VC, lliff LD, Zilkha E, DuBoulay GH, McAllister VL, Marshall J, Russel WR. Symon L: Cerebral blood flow in dementia. Arch Neurol 1975:32:632-637
31. Folstein MF, Folstein SE, McHugh PR: ‘Mini-Mental State’: A practical mclhod for grading the cognitive stale of patients for the clinician. J PsychiatrRcs 1975;12:189-198.
32. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Psychol 1967:6:278-296.
33. Asberg M, Montgomery S, Pcrris C, Schalling D, Sedvall G: Psychiatric rating scale for depression. Acta Psvchiatr Scand 1978 (suppl 271):5-27.
34. Spielberger CD, Gorsuch RI, Lushene RE: STAI. Manual for the State-Trait Anxiety Inventory. Palo Alto, Consulting Psychological Press Inc., 1970.
35. Talairach J, Toumoux P: Coplanar stereotaxic atlas of the human brain. Three dimensional proportional svstenv. An approach to cerebral imaging. Stuttgart. Thicmc, 1988.
36. Hunter R, Wyper DJ, Patterson J, Hansen MT, Goodwin GM: Cerebral pharmacodynamics of physiostigminc in Alzheimer’s disease investigated using single-photon computerised tomography. Br J Psychiatry 1991:158:351-357.
37. Gustafson L, Edvinsson L, Dahlgrcn N, Hag-berg R, Risberg J, Rosen I, Fcmo H: Intravenous phvsostigmine ireatmenl of Alzheimer’s disease evaluated by psychometric testing, regional cerebral blood flow rCBF] measurement, and EEG. Psycho pharmacology 1987; 93:31-35.
38. Kawakatsu S, Shinohara M, Higashitani Y, Morinobu S, Sagawa K, Komatani A, Totsuka S: Oral administration of physostigmine in Alzheimer type dementia: The neuropsychological assessment by SPECT and EEG mapping. Biol Psychiatry 1991;29:228S.
39. Geancy DP, Soper N, Shcpslone HI, Co wen PJ: Elfcct of central cholinergic slimulation on regional cerebral blood low in Alzheimer disease. Lancet 1990;335:1484-1487.
40. Besson JA, Crawford JR, Evans NT, Gemmell HG, Roeda D: PET imaging in Alzheimer’s disease. J R Soc Med 1992;85:231-234.
41. Bonte FJ, Devous MD, Reisch JS, Ajmani AK, Weiner MF, Horn J, Tininer R; The effect of acetazolamide on regional cerebral blood low in patients with Alzheimer’s disease or stroke as measured by singlc-phoion emission computed tomography. Invest Radiol 1989:24;99-103.
42. Kuwabara Y, Ichiya Y, Otsuka M, Mnstida K, Ichimiya H, Fujishima M: Cerebrovascular responsiveness to hypercapnia in Alzheimer’s dementia and vascular dementia of the Bitis-wanger type, Stroke 1992:23:594-598.
43. Miller JD, DcLcon MJ, Ferris SH, Kluger A, George AE, Reisbcrg B, Sachs HJ, Wolf HP: Abnormal temporal lobe response in Alzheimer’s disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. J Cereb Blood Flow Metab 1987:7:248-251.
44. Buchsbaum MS, Kesslak JP, Lynch G, Chui H, Wu J, Sicotte N, Hazlette E, Teng E, Cotman CW: Temporal hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer’s type and controls, Preliminary studies Arch Gen Psvchi.itn 1991;48:840-847.
45. Kessler J, Herholz K, Grond M, Heiss WD: Impaired metlfcolit activation m Alzhtimtr c disease. A PET sludv during continuous visual recognition. Neuropsvchologia 1991:29/3:229-243.
46. Perry EK, Tomlinson BE, Blessed G: Correlation of cholinergic abnormalities with senile plaques and mental lest scores in dementia. Br Med J. l978:11:1457-1459.
47. Wilcock GK, Esiri MM, Bowcn DM: Alzheimer’s disease: Correlation of cortical choline aceivl transferase activity with the severity ot dementia and histological abnormalities. J Neurol Sci 1982:56:407-417.
48. Edvinsson L, MacKenzic ET, McCulloch J; Cerebral Blood Flow and Metabolism. Raven Press, New York. 1993.
49. Armstrong DM; Urastruciural characterization of choline acctyltransferase-containing neurons in the basal forebrain of rat: Evidence for a cholinergic innervation of intracerebral blood vessels. J Comp Neurol 1986:250:81-92.
50. Gitelmau DR, Prohovnik I: Muscarinic and nicotinic contributions to cognitive function and cortical blood flow. Neurobiol Aging 1992: 13:313-318.
51. Lou HC, Edvinsson L, Mackenzie ET: The concept of coupling blood flow lo brain function: Revision required? Ann Neurol 1987:22:289-297.
52. Ehrenreich DL, Bums RA, Alman RW, Faze-kas JF: Influence of acetazolamide on cerebral blood flow. Arch Neurol 1961:5:227-232.
53. Gotoh F, Shinohara Y: The role of carbonic anhydrase in chemical control and auloregula-lion of cerebral circulation. Ini J Neurol 1977; 11:219-227.
54. Dingier WH, Dcininger HK.: Wcrtigkcit des Acctazolamid-Stimulations-Tcsts mit der 99mTc-HMPAO-SPECT bci rcvcrsibler ccre-brovaskularcr Insuffizienz (CV1), Fonschr Rbntgenstt 1991:155:465-471.
55. Holman BL, Nagel JS, Johnson KA, Hill TO Imaging dementia with SPECT. Ann NY Acad Sci 1991;620:165-174.
56. Vcrhoeff NPLC, Biill U, Costa DC, Kirsch G, Lottcs G, Moretti JL, Podrcka L, Schober O, van Royen EA: Basics and recommendations for brain SPECT. Nucl Med 1992:31:114-131.
57. Matsuda H, Tsuji S, Shuke N, Sumiya H, Ton-ami N. Hisada K: Noninvasive measurements of regional cerebral blood flow using technetium -99m hexamethylpropylene amine oxime. Eur J Nucl Med 1993;20:391-401.
58. Shcdlack KJ, Hunter R, Wyper D, McLuskie R, Fink G, Goodwin GM: The pattern of cerebral activity underlying verbal fluency shown by split dose single photon emission tomography (SPET or SPECT) in normal volunteers. Psychol Med 1991:21:687-696.
59. Ebmeier KP, Dougall NJ. Austin MP, Curran SM, Murray C, Goodwin GM: The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker cxametazime and single photon emission computed tomography (SPECT); Reproducibility and rater reliability. Int J Methods Psychiatr Res 1991;1:27-38.
60. Rogers RL, Meyer JS, Mahurin RK, Thoraby J: Age-related reductions in cerebral vasomotor reactivity and the law of initial value: A 4-year prospective longitudinal study, J Cercb Blood RowMetab 1984;5:79-85.
61. Reich T, Rusinek H: Cerebral cortical and white matter reactivity to carbon dioxide. Stroke 1989;20:453-457.
62. Davis SM, Ackerman RH, Correia JA, Alpcrt NM, Chang JC, Buonanno F, Kelly RE, Rosner B, Taveras J: Cerebral blood flow and cerebrovascular CO: reactivity in stroke-age normal controls. Neurology 1983:33:391-399.
63. Kreisig T, Schmiedek P, Leinsinger G, Ein-haupl K, Moser E: Xe-DSPECT: Normahvertc von zcrcbralcr Ruhedurchblutung und Reser-vekapazit3t. Nucl Med 1987;26:192-197.
64. Austin MP, Dougall N, Ross M, Murray C, O’Carroll RE, Moffoot A, Ebmeier KP, Goodwin GM; Single photon emission tomography with "Tc-hexamctazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord 1992:26:31-44.
65. Philpot MP, Banerjee S, Need ham-Bennett H, Costa DC, Ell PJ: mTc-HMPAO single photon emission tomography in late life depression: A pilot study of regional cerebral blood flow at rest and during a verbal fluency task. J Affect Disord 1993;28:233-240.
66. Gur RE, Resnick SM, Gur RC, Alavi A, Caroff S, Kushncr M, Reivich M: Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. Arch Gen Psychiatr 1987;44:126-129.
67. Wolkin A, Jager J, Brodic JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R: Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985;142:564-571.
68. Theodore WH, DiChiro G, Margolin R, Fish-bein D, Porter RJ, Brooks RA: Barbiturates reduce human cerebral glucose metabolism. Neurology 1986:36:60-64.
69. Mann DMA, Yates PO, Hawkes J: The noradrenergic system in Alzheimer and multi-infarct dementias. J Neuroi Neurosurg Psychiatry 1982;45:113-119.
70. Kalaria RN: The blood-brain barrier and cerebral microcirculation in Alzheimer’s disease. Cercbrovasc Brain Metab Rev 1992;4;226-260.
71. Price DL, Walker LC, Martin U, Sisodia SS; Amyloidosis in aging and Alzheimer’s disease. Am J Pathol 1992;141:767-772.
72. Prelli F, Castano E, Glenner CG, Frangione B: Differences between vascular and plaque core amyloid in Alzheimer’s disease. J Neurochem 1988:51:648-651.
73. Jellingcr KA: Distribution of amyloid plaques in the cerebellum in Alzheimer’s disease. Acta Neuropathol 1993:85:682.
74. Ehrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE, Burd PR: Thrombin is a regulator of astrocytic endothclin-l. Brain Res 1993;600:201-207.
75. Macrae M, Robinson MJ, Graham DI, Reid JL, McCulioch J: Endothelin-1-induced reductions in cerebral blood flow: Dose dependency, time course, and neuropathological consequences, J Cereb Blood Row Metab 1993:13: 276-284.
76. ldc K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K: The role or endothclin in the pathogenesis of vasospasm following subarachnoid hemorrhage. Neurol Res 19S9; 11:101-104.
77. Yanagisawa M, Kuirhara H, Kimura S, To-mobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T; A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
78. Wagner SL, Gcddes JW, Cotman CW, Latl AL, Gurwitz D, Isackson PJ, Cunningham DD: Protease nexin-1, an antithrombinxviih neurite outgrowth activity, is reduced in Alzheimer’s disease. Proc Natl Acad Sci USA 1989:86: 8284-8288.
79. Akiyama H, Ikeda K, Kondo H, McGccr PL: Thrombin accumulation in brains of patients with Alzheimer’s disease, Neurosei Lett 1992: 146:152-154.
80. Navcteur J, Roy JC, Ovelac E, Steinling M: Anxiety, emotion and cerebral blood now. Int J Psychophysiol 1992;13:137-146.
81. Stoppc G, Staedt J: Die friihe diagnostische Differenzierung primar demcntcr von primar depiessiven Syndromen im Alter - ein Beitrag zur Pseudodemenzdiskussion. Fortschr Neurol Psychiatr 1993;61:172-182.
82. Warren LR, Butler RW, Katholi CR, McFar-land CE, Crews EL, Halsey JH: Focal changes in cerebral blood flow produced by monetary incentive during a menial mathematical task in normal and depressed subjects. Brain Cogn 1984:3:71-85.
83. Schlegel S, Aldenhoff JB, Eissner D, Lindner P, Nickel O: Regional cerebral blood flow in depression: Associations with psychopathology. J Affect Disord 1989; 17:211-218.